Management of Mast Cell Activation Disorder in Children

Introduction to Treatment

The American Academy of Dermatology recommends starting with H1 antihistamines (such as cetirizine, diphenhydramine, or hydroxyzine) as first-line therapy for children with mast cell activation disorder, adding H2 antihistamines (ranitidine or famotidine) if gastrointestinal symptoms persist, and prescribing an epinephrine autoinjector for emergency use during severe reactions 1, 2, 3

The American College of Allergy, Asthma, and Immunology suggests beginning with H1 antihistamines to control itching, flushing, skin rashes, and rapid heartbeat, with effective options including diphenhydramine, hydroxyzine, and cetirizine 1, 2, 3
The American Academy of Pediatrics recommends that doses of H1 antihistamines may need to be 2-4 times higher than FDA-approved levels for adequate symptom control, and high doses can cause cardiotoxicity, requiring careful monitoring 1, 2, 3
The American Gastroenterological Association advises adding H2 antihistamines such as ranitidine or famotidine if gastrointestinal symptoms persist despite H1 antihistamines alone, as combined H1 and H2 therapy is particularly effective for controlling severe pruritus and wheal formation when monotherapy fails 1, 2, 3

The American Heart Association recommends that every child with mast cell activation disorder must have an epinephrine autoinjector prescribed and caregivers trained in its use, and administered intramuscularly in a recumbent position immediately for hypotension, wheezing, laryngeal edema, cyanotic episodes, or recurrent anaphylactic attacks 1, 2, 3

The American Academy of Dermatology suggests identifying and avoiding triggers, including temperature control, as mast cells can be activated by hot temperatures and, to a lesser extent, cold temperatures, and rational use of baths, showers, swimming pools, and air conditioning can decrease symptoms and reduce the need for antihistamines 1, 2, 3
The American Psychological Association recommends avoiding anxiety and stress, as they can trigger mast cell activation, and controlling pain, as it can also trigger mast cell activation, with safer opioid options including fentanyl and remifentanil 1, 2, 4

The American Academy of Pediatrics recommends educating parents and caregivers, as it directly improves quality of life, and communicating with pediatricians, teachers, school nurses, and daycare workers about the diagnosis, treatment, and potential risks, including infections, vaccinations, dental work, imaging procedures, and surgery 1, 2, 3

The American Academy of Dermatology states that the long-term prognosis for children with mast cell activation disorder is favorable, with symptoms usually improving significantly after the first 6 to 18 months, and many children experiencing spontaneous resolution as they grow older 1